Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12565143rdf:typepubmed:Citationlld:pubmed
pubmed-article:12565143lifeskim:mentionsumls-concept:C0036751lld:lifeskim
pubmed-article:12565143lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:12565143lifeskim:mentionsumls-concept:C0001962lld:lifeskim
pubmed-article:12565143lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12565143lifeskim:mentionsumls-concept:C0162585lld:lifeskim
pubmed-article:12565143lifeskim:mentionsumls-concept:C0279023lld:lifeskim
pubmed-article:12565143lifeskim:mentionsumls-concept:C0049231lld:lifeskim
pubmed-article:12565143pubmed:issue1lld:pubmed
pubmed-article:12565143pubmed:dateCreated2003-2-4lld:pubmed
pubmed-article:12565143pubmed:abstractTextWe examined the effect of 5-hydroxyindole (5-HI) on the potentiation of 5-hydroytryptamine (5-HT)(3) receptor function by ethanol (EtOH) so as to study whether EtOH potentiates channel function through increasing activation or blocking desensitization. We measured 5-HT(3) receptor current using a whole-cell voltage clamp technique with a method of rapid drug application in NCB-20 neuroblastoma cells. The 5-HI, an agent that block receptor desensitization, increased the decay time constant (tau), not the peak of 5-HT(3) receptor-mediated currents induced by 10 microM 5-HT. EtOH did not change the peak amplitude and tau of the current induced by 10 microM 5-HT. Coapplication of EtOH and 5-HI with 5-HT caused no increase in the peak currents, but tau was further increased. Therefore, a further block in desensitization could be induced by 5-HI, despite the presence of EtOH. These results indicate that EtOH potentiates 5-HT(3) receptor function, with these effects due at least in part by increasing channel activation rather than by blocking desensitization.lld:pubmed
pubmed-article:12565143pubmed:languageenglld:pubmed
pubmed-article:12565143pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:citationSubsetIMlld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12565143pubmed:statusMEDLINElld:pubmed
pubmed-article:12565143pubmed:monthFeblld:pubmed
pubmed-article:12565143pubmed:issn0304-3940lld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:KimOk NyuONlld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:LeeSang BokSBlld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:KimSeong...lld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:SungKi-WugKWlld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:YangHan SooHSlld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:ChoiSe JoonSJlld:pubmed
pubmed-article:12565143pubmed:authorpubmed-author:KimKi-JungKJlld:pubmed
pubmed-article:12565143pubmed:copyrightInfoCopyright 2002 Elsevier Science Ireland Ltd.lld:pubmed
pubmed-article:12565143pubmed:issnTypePrintlld:pubmed
pubmed-article:12565143pubmed:day20lld:pubmed
pubmed-article:12565143pubmed:volume338lld:pubmed
pubmed-article:12565143pubmed:ownerNLMlld:pubmed
pubmed-article:12565143pubmed:authorsCompleteYlld:pubmed
pubmed-article:12565143pubmed:pagination72-6lld:pubmed
pubmed-article:12565143pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:meshHeadingpubmed-meshheading:12565143...lld:pubmed
pubmed-article:12565143pubmed:year2003lld:pubmed
pubmed-article:12565143pubmed:articleTitleEffect of 5-hydroxyindole on ethanol potentiation of 5-hydroxytryptamine (5-HT)3 receptor-activated ion current in NCB-20 neuroblastoma cells.lld:pubmed
pubmed-article:12565143pubmed:affiliationDepartment of Pharmacology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul 137-701, South Korea.lld:pubmed
pubmed-article:12565143pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12565143pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed